Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 87, Issue S1, Pages S141-S145
Publisher
Wiley
Online
2012-03-14
DOI
10.1002/ajh.23202
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Antithrombotic Drugs
- (2012) Jeffrey I. Weitz et al. CHEST
- Evidence-Based Management of Anticoagulant Therapy
- (2012) Anne Holbrook et al. CHEST
- Prothrombin Complex Concentrate for Critical Bleeding
- (2011) Asad E Patanwala et al. ANNALS OF PHARMACOTHERAPY
- The Use of Dabigatran in Elderly Patients
- (2011) Matthieu Legrand ARCHIVES OF INTERNAL MEDICINE
- Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate
- (2011) Elise S. Eerenberg et al. CIRCULATION
- Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial
- (2011) K.-H. LIESENFELD et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Acutely Injured Patients on Dabigatran
- (2011) Bryan A. Cotton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients
- (2011) Samuel Z. Goldhaber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
- (2011) John H. Alexander et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor Dabigatran
- (2011) Wei Zhou et al. STROKE
- Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists
- (2011) Chiara Marchesi et al. THROMBOSIS AND HAEMOSTASIS
- Questions and answers on the use of dabigatran and perpectives on the use of other new oral anticoagulants in patients with atrial fibrillation.
- (2011) Luciano Crippa et al. THROMBOSIS AND HAEMOSTASIS
- New antithrombotics: The impact on global health care
- (2011) Charles E. Mahan et al. THROMBOSIS RESEARCH
- Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor
- (2010) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate
- (2010) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Safety of Recombinant Activated Factor VII in Randomized Clinical Trials
- (2010) Marcel Levi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents
- (2009) M. A. CROWTHER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now